��������

Andrea Santos Cáceres, PhD is a scientist with experience in molecular biomedicine, clinical research, and regulatory affairs. Andrea has worked on projects related to PP2A signaling inhibition in cancer, autophagy-mediated cell death in glioma, and gene expression profile in leukemia. Andrea holds a PhD in Molecular Biosciences from Universidad Autónoma de Madrid and has completed both Master's and Bachelor's degrees in related fields. Currently, Andrea serves as a Regulatory Affairs & Start-up Specialist at NEXT Oncology.